CVS Health's third quarter revenue of $108.4B beat expectations while full-year guidance was raised

CVS Health reported third quarter 2026 results that significantly outperformed analyst expectations on both revenue and earnings. The performance was characterized by a recovery in insurance margins and strong pharmacy volumes, prompting management to raise full-year guidance for earnings and operating cash flow.

Key Highlights

• Total revenues rose 5.4% year-over-year to $108.4 billion, exceeding the $105.04 billion consensus estimate.
• Adjusted EPS reached $2.09, well ahead of the $1.62 estimate, supported by execution of the Health Care Benefits margin recovery plan.
• The Medical Benefit Ratio (MBR) improved to 91.3% from 92.8% in the prior year, primarily driven by underlying performance gains in the Government insurance business.
• Full-year 2026 Adjusted EPS guidance was raised to at least $8.20, while cash flow from operations guidance was increased from $11.5 billion to at least $15.5 billion.